ProCE Banner Series

A Practical Skills Course on New and Emerging Targets for Crohn’s Disease: Equipping NPs and PAs to Enhance Patient–Provider Therapeutic Connections to Optimize Outcomes

Deepen your understanding of treat-to-target guidelines in Crohn’s disease, including noninvasive imaging strategies to detect inflammation, and improve your communication with patients to empower them to more openly discuss disease burden.

  AAPA
  | ANCC
Who Should Attend

This program is intended for gastroenterology nurse practitioners and physician associates who manage patients with CD.

Topics

Inflammatory bowel disease 

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
The goal of this continuing education activity is to enhance learners’ knowledge, competence, and performance in patient-centered care for CD using a treat-to-target approach, assessing and discussing bowel urgency, and advancing clinical and endoscopic outcomes for patients to improve quality of life.

Target Audience
This program is intended for gastroenterology nurse practitioners and physician associates who manage patients with CD.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Apply expert consensus T2T guidance when evaluating treatment response and treatment advancement in patients with moderate to severe CD
  • Leverage noninvasive imaging to assess mucosal and transmural inflammation in patients with CD
  • Leverage expert guidance and evidence-based communication strategies that engage and empower patients to discuss the burden of CD—including bowel urgency—during patient visits

Accreditation

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and Smart Patients. Partners for Advancing Clinical Education (PACE) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour, including 1.0 hour of pharmacotherapy credit.

Physician Associate Continuing Medical Education

PACE has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim commensurate with the extent of their participation.

Disclosure of Conflicts of Interest
PACE requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships are mitigated according to PACE policies.

Acknowledgement

Provided by Partners for Advancing Clinical Education (PACE) in partnership with Smart Patients 

This activity is supported by an educational grant from Lilly.